Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsFILM COATEDGeneric

SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE

METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE

Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 216885 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE Form and strength TABLET;FILM COATED - 500MG Sponsor PRINSTON PHARMACEUTICAL INC Submission history Latest submission status date: 2025-03-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 216885 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE Form and strength TABLET;FILM COATED - 500MG Sponsor PRINSTON PHARMACEUTICAL INC Submission history Latest submission status date: 2025-03-13 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE) | Drug Monograph | MedicHelpline